Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frieman

Showing results (201-210 of 247) with videos related to

Pageof 25
Sort By:
Plos Genetics|October 10, 2015
Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative CrossLisa E Gralinski, Martin T Ferris, David L Aylor, et al.
Iscience|November 21, 2024
The BNT162b2 mRNA vaccine demonstrates reduced age-associated T<sub>H</sub>1 support <i>in vitro</i> and <i>in vivo</i>Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Journal of Extracellular Vesicles|November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Science Translational Medicine|February 19, 2016
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivoThomas Luke, Hua Wu, Jincun Zhao, et al.
The New England Journal of Medicine|September 3, 2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineCheryl Keech, Gary Albert, Iksung Cho, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Pageof 25

Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
Plos Genetics|October 10, 2015
Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative CrossLisa E Gralinski, Martin T Ferris, David L Aylor, et al.
Iscience|November 21, 2024
The BNT162b2 mRNA vaccine demonstrates reduced age-associated T<sub>H</sub>1 support <i>in vitro</i> and <i>in vivo</i>Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Journal of Extracellular Vesicles|November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Science Translational Medicine|February 19, 2016
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivoThomas Luke, Hua Wu, Jincun Zhao, et al.
The New England Journal of Medicine|September 3, 2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineCheryl Keech, Gary Albert, Iksung Cho, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Pageof 25